Manuscripts
Showing 1596 manuscripts.
Communication in the management of uncertainty: the case of persons living with HIV or AIDS
Citation
Dale E. Brashers, Ph.D., Judith Neidig, R.N., Ph.D., Stephen M. Haas, Linda K. Dobbs, Ph.D., Linda W. Cardillo, M.A., Jane A. Russell, R.N. Communication in the management of uncertainty: the case of persons living with HIV or AIDS. Communication Monographs. 2000 Mar 01; 67(1):63-84.Year
2000
Journal
Communication Monographs
Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men
Citation
Catherine Diamond, Carl E. Speck, Meei-Li Huang, Lawrence Corey, M.D., Robert W. Coombs, M.D., Ph.D., John N. Krieger. Comparison of assays to detect cytomegalovirus shedding in the semen of HIV-infected men. Journal of Virological Methods. 2000 Nov 01; 90(2):185-91.Year
2000
Journal
Journal of Virological Methods
Single Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1
Citation
Walter T. Hughes, Jerry L. Shenep, John H. Rodman, Arnold Fridland, Rodney Willoughby, Suzette Blanchard, Lynette Purdue, Dion F. Coakley, Kenneth C Cundy, Mary Culnane, C.R.N.P., M.S., Bonnie Zimmer, B.S., Sandra K. Burchett, M.D., M.S., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H. Single Dose Pharmacokinetics and Safety of the Oral Antiviral Compound Adefovir Dipivoxil in Children Infected with Human Immunodeficiency Virus Type 1. Antimicrobial Agents and Chemotherapy. 2000 Apr 01; 44(4):1041-6.Year
2000
Journal
Antimicrobial Agents and Chemotherapy
Use of HIV-IVIG In HIV-1 Infected Children (PACTG 273)
Citation
E. Richard Stiehm, M.D., Courtney V. Fletcher, Pharm.D., Lynne M. Mofenson, M.D., F.A.A.P., Paul Palumbo, M.D., Minhee Kang, M.S., Ph.D., Terence Fenton, Ed.D., Christine Sapan, Ph.D., William A. Meyer, III, Ph.D., William T. Shearer, M.D., Ph.D., Elizabeth Hawkins, James McNamara, M.D., Mary Glenn Fowler, M.D., M.P.H., Pamela Bouquin, B.A., Lynette Purdue, Pharm.D., Elaine M. Sloand, M.D., George J. Nemo, Ph.D., Diane W. Wara, M.D., Yvonne J. Bryson, M.D., Stuart E. Starr, M.D., Ann Petru, M.D., Kenneth McIntosh, M.D. Use of HIV-IVIG In HIV-1 Infected Children (PACTG 273). Journal of Infectious Diseases. 2000 Feb 01; 181(2):548-54.Year
2000
Journal
Journal of Infectious Diseases
Immunologic Response To Combination Nucleoside Analogue Plus Protease Inhibitor Therapy In Stable Antiretroviral Therapy-Experienced HIV-Infected Children
Citation
William Borkowsky, M.D., Kenneth Stanley, Ph.D., Steven D. Douglas, M.D., Sophia S. Lee, M.S., Andrew A. Wiznia, M.D., Stephen Ira Pelton, M.D., Ram Yogev, M.D., Kenneth McIntosh, M.D., Susan A. Fiscus, Ph.D., Sharon Appelbaum Nachman, M.D. Immunologic Response To Combination Nucleoside Analogue Plus Protease Inhibitor Therapy In Stable Antiretroviral Therapy-Experienced HIV-Infected Children. Journal of Infectious Diseases. 2000 Jun 01; 182(1):96-103.Year
2000
Journal
Journal of Infectious Diseases
Discontinuation of mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team
Citation
Judith Silverstein Currier, M.D., M.Sc., Paige L. Williams, Ph.D., Susan L. Koletar, M.D., Susan Ellen Cohn, M.D., M.P.H., Robert L. Murphy, M.D., Alison Heald, M.D., Richard Hafner, M.D., Ehab Bassily, M.Sc., Howard M. Lederman, M.D., Ph.D., Charles Knirsch, M.D., M.P.H., Constance A. Benson, M.D., Hernan Valdez, M.D., Judith A. Aberg, M.D., J. Allen McCutchan, M.D., M.Sc. Discontinuation of mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team. Annals of Internal Medicine. 2000 Oct 03; 133(7):493-503.Year
2000
Journal
Annals of Internal Medicine
Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors
Citation
Mark A. Winters, M.S., Kristi L. Coolley, Peng Cheng, Yvette A. Girard, Hasnah Hamdan, Ladislau C. Kovari, Thomas C. Merigan, Jr., M.D. Genotypic, phenotypic, and modeling studies of a deletion in the beta3-beta4 region of the human immunodeficiency virus type 1 reverse transcriptase gene that is associated with resistance to nucleoside reverse transcriptase inhibitors. Journal of Virology. 2000 Nov 01; 74(22):10707-13.Year
2000
Journal
Journal of Virology
Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests
Citation
J. Robins, Dianne M. Finkelstein, Ph.D. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000 Sep 01; 56(3):779-88.Year
2000
Journal
Biometrics
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks
Citation
Charles Raines, C.R.N.P., M.S.N, Charles Flexner, M.D., Eugene Sun, M.D., Margo E. Heath-Chiozzi, M.D., Ronald Lewis, M.D., Catherine Fields, C. Deetz, Linda Apuzzo, B.S., C.C.R.C., Susan H. Eshleman, M.D., PH.D., Brooks Jackson, M.D., M.B.A., Joel E. Gallant, M.D., M.P.H. Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. Journal of Acquired Immune Deficiency Syndromes. 2000 Dec 01; 25(4):322-8.Year
2000
Journal
Journal of Acquired Immune Deficiency Syndromes
Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children
Citation
Leock Y. Ngo, Ram Yogev, Wayne M. Dankner, Walter T. Hughes, Sandra Burchett, Jing Xu, Brian Sadler, Jashvant D. Unadkat. Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999 Jun 01; 43(6):1516-19.Year
1999
Journal
Antimicrobial Agents and Chemotherapy